VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DOX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DOXAmdocs Limited
$51.45$5.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDOXFinancials

Amdocs Limited (DOX) Financials

29Y historyFree accessUpdated daily

Revenue growth has faced significant cyclical headwinds, evidenced by a contraction of 9.43% in 2025Q2, while gross margins remain tightly clustered around the 37% level.

DOX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97
Sales/Revenue4.62B4.53B5B4.89B4.58B4.29B4.17B4.09B3.97B3.87B3.72B3.64B3.56B3.35B3.25B3.18B2.98B2.86B3.16B2.84B2.48B2.04B1.77B1.48B1.61B1.53B1.12B626.9M403.8M290.1M
Revenue Growth %-2.73%-9.43%2.4%6.79%6.72%2.87%2.02%2.81%2.78%4.01%2.05%2.24%6.51%3.05%2.18%6.48%4.25%-9.47%11.49%14.36%21.65%14.93%19.58%-8.07%5.19%37.16%78.39%55.25%39.19%-
Cost of Goods Sold2.9B2.87B3.25B3.16B2.96B2.81B2.76B2.65B2.6B2.51B2.41B2.35B2.31B2.17B2.09B2.07B1.91B1.83B2.03B1.8B1.58B1.3B1.12B913.36M933.34M853.24M645.52M332.7M213M169M
COGS % of Revenue-63.42%64.93%64.65%64.62%65.54%66.1%64.92%65.29%64.84%64.76%64.48%64.73%64.77%64.23%65.12%63.86%64.09%64.08%63.34%63.86%63.56%63.3%61.58%57.84%55.63%57.72%53.07%52.75%58.26%
Gross Profit1.73B1.66B1.76B1.73B1.62B1.48B1.41B1.43B1.38B1.36B1.31B1.29B1.26B1.18B1.16B1.11B1.08B1.03B1.14B1.04B896.22M742.97M650.9M569.97M680.23M680.67M472.8M294.2M190.8M121.1M
Gross Margin %37.33%36.58%35.07%35.35%35.38%34.46%33.9%35.08%34.71%35.15%35.24%35.52%35.27%35.23%35.77%34.88%36.14%35.91%35.92%36.66%36.14%36.44%36.7%38.42%42.16%44.37%42.28%46.93%47.25%41.74%
Gross Profit Growth %--5.54%1.61%6.7%9.57%4.54%-1.4%3.91%1.48%3.76%1.25%2.97%6.61%1.5%4.79%2.76%4.92%-9.49%9.23%16.02%20.63%14.14%14.2%-16.21%-0.06%43.97%60.71%54.19%57.56%-
Operating Expenses918.22M834.71M1.13B1.07B954.35M878.98M818.72M863.75M866.2M842.17M827.05M765.1M761.1M697.25M718.96M704M668.12M639.88M716.31M675.6M538.37M391.88M354.7M345.46M579.44M521.39M398.67M147.2M105.9M66.6M
OpEx % of Revenue-18.41%22.51%21.97%20.85%20.5%19.64%21.14%21.79%21.78%22.24%21%21.36%20.84%22.14%22.15%22.39%22.35%22.65%23.82%21.71%19.22%20%23.29%35.91%33.99%35.65%23.48%26.23%22.96%
Selling, General & Admin518.02M493.87M572.85M570.71M528.57M487.25M458.54M492.46M481.09M472.78M464.88M440.08M445.13M418.57M424.67M409.46M373.58M344.33M404.13M370.19M314M232.07M210.38M206.26M223.55M195.59M137M75.7M51.2M40.8M
SG&A % of Revenue-10.9%11.45%11.68%11.55%11.36%11%12.05%12.1%12.23%12.5%12.08%12.49%12.51%13.08%12.89%12.52%12.03%12.78%13.05%12.66%11.38%11.86%13.91%13.85%12.75%12.25%12.08%12.68%14.06%
Research & Development343.69M340.85M360.8M374.86M354.71M312.94M282.04M273.94M276.62M259.1M252.29M254.94M257.9M240.27M242.06M221.89M207.84M210.39M225.49M230.44M186.76M144.46M126.41M119.26M124.08M105.81M74.85M40.9M25.6M17.4M
R&D % of Revenue-7.52%7.21%7.67%7.75%7.3%6.77%6.7%6.96%6.7%6.79%7%7.24%7.18%7.46%6.98%6.96%7.35%7.13%8.13%7.53%7.09%7.13%8.04%7.69%6.9%6.69%6.52%6.34%6%
Other Operating Expenses3M0193.14M128.06M71.08M78.78M78.14M97.36M108.49M110.29M109.87M70.07M58.07M38.41M52.23M72.65M86.7M85.15M86.69M74.96M37.61M15.36M17.91M19.94M231.8M219.99M186.82M30.6M29.1M8.4M
Operating Income807.34M823.36M628.61M653.99M664.8M598.69M594.76M569.75M428.31M517.33M483.14M515.95M495.65M481.55M442.47M404.36M410.43M367.32M405.6M357.43M332.13M338.49M296.2M210.42M49.16M159.28M74.12M147M84.9M54.5M
Operating Margin %17.47%18.16%12.56%13.38%14.53%13.96%14.27%13.94%10.78%13.38%12.99%14.16%13.91%14.39%13.63%12.72%13.75%12.83%12.83%12.6%13.39%16.6%16.7%14.19%3.05%10.38%6.63%23.45%21.03%18.79%
Operating Income Growth %-30.98%-3.88%-1.63%11.04%0.66%4.39%33.02%-17.21%7.08%-6.36%4.1%2.93%8.83%9.42%-1.48%11.74%-9.44%13.47%7.62%-1.88%14.28%40.77%328.02%-69.14%114.88%-49.58%73.14%55.78%-
EBITDA1.01B1.02B821.67M849.69M889.33M807.52M793.17M775.52M639.53M732.22M694.93M690.74M658.42M622.33M602.09M585.84M606.37M565.44M598.53M522.43M450.03M432.32M397.08M307.87M358.98M441.91M229.48M177.6M114M62.9M
EBITDA Margin %21.93%22.48%16.42%17.38%19.43%18.83%19.03%18.98%16.09%18.93%18.69%18.96%18.48%18.6%18.54%18.44%20.32%19.75%18.93%18.42%18.15%21.21%22.39%20.76%22.25%28.81%20.52%28.33%28.23%21.68%
EBITDA Growth %16.1%23.99%-3.3%-4.46%10.13%1.81%2.28%21.26%-12.66%5.37%0.61%4.91%5.8%3.36%2.77%-3.39%7.24%-5.53%14.57%16.09%4.1%8.88%28.98%-14.24%-18.77%92.57%29.21%55.79%81.24%-
D&A (Non-Cash Add-back)206.36M195.44M193.07M195.7M224.53M208.83M198.41M205.77M211.22M214.88M211.79M174.79M162.77M140.78M159.61M181.48M195.94M198.12M192.94M164.99M117.9M93.83M100.88M97.45M309.82M282.63M155.36M30.6M29.1M8.4M
EBIT745.61M731.66M625.96M659.45M665.32M835.58M593.75M571.8M424.31M514.51M486.37M516.55M493.03M479.03M444.7M398.59M388.43M374.02M448.44M364.19M357.86M351.09M296.2M224.51M100.79M159.28M74.12M147M84.9M54.5M
Net Interest Income-40.78M-33.28M-17.44M-1.84M-9.09M-16.45M-6.19M2.31M3.84M6.37M5.15M1.47M-8.49M-2.79M2.3M1.08M3.81M8.51M11.96M00000000000
Interest Income-11.27M9.15M17.45M21.25M7.82M4.82M4.23M6.22M6.6M7.97M6.82M4.62M4.08M4.92M5.48M6.18M7.67M16.37M42.84M00000000000
Interest Expense29.51M42.44M34.89M23.09M16.91M21.27M10.43M3.91M2.76M1.6M1.67M3.14M3.48M3.56M3.17M2.88M3.13M7.87M30.88M00000000000
Other Income/Expense-123.49M-130.12M-37.54M-17.63M-16.39M215.61M-11.44M-1.86M-6.77M-4.42M1.56M-2.54M-6.1M-6.08M-948K-8.66M-25.14M-1.17M11.96M50.57M41.74M22.3M4.9M14.76M19.3M22.29M10.73M-6.3M-24.1M-30.8M
Pretax Income683.86M693.24M591.07M636.36M648.41M814.31M583.32M567.89M421.54M512.91M484.7M513.4M489.55M475.48M441.52M395.71M385.3M366.15M417.55M408M373.87M360.8M301.1M225.18M68.46M181.57M84.86M140.8M60.8M23.7M
Pretax Margin %14.79%15.29%11.81%13.02%14.17%18.99%13.99%13.9%10.61%13.26%13.04%14.09%13.74%14.21%13.6%12.45%12.91%12.79%13.2%14.39%15.08%17.7%16.98%15.18%4.24%11.84%7.59%22.46%15.06%8.17%
Income Tax134.71M125.47M94.75M93.4M98.91M125.93M85.48M88.44M67.14M76.09M75.37M67.24M67.43M63.04M50.15M49.04M41.39M39.98M38.65M43.06M55.24M72.16M66.24M56.29M73.52M115.18M78.88M42.2M30.4M17.8M
Effective Tax Rate %19.7%18.1%16.03%14.68%15.25%15.46%14.65%15.57%15.93%14.83%15.55%13.1%13.77%13.26%11.36%12.39%10.74%10.92%9.26%10.55%14.77%20%22%25%107.39%63.44%92.96%29.97%50%75.11%
Net Income546.5M564.7M493.2M540.71M549.5M688.37M497.84M479.45M354.4M436.83M409.33M446.16M422.12M412.44M391.37M346.67M343.91M326.18M378.91M364.94M318.64M288.64M234.86M168.88M-5.06M66.39M5.98M98.5M30.1M5.9M
Net Margin %11.82%12.46%9.85%11.06%12.01%16.05%11.94%11.73%8.92%11.3%11.01%12.25%11.85%12.33%12.05%10.91%11.52%11.39%11.98%12.87%12.85%14.16%13.24%11.39%-0.31%4.33%0.53%15.71%7.45%2.03%
Net Income Growth %1%14.5%-8.79%-1.6%-20.17%38.27%3.84%35.29%-18.87%6.72%-8.26%5.7%2.35%5.38%12.9%0.8%5.44%-13.92%3.83%14.53%10.39%22.9%39.07%3436.95%-107.62%1010.51%-93.93%227.24%410.17%-
Net Income (Continuing)549.14M567.77M496.32M542.96M549.5M688.37M497.84M479.45M354.4M436.83M409.33M446.16M422.12M412.44M391.37M346.67M343.91M326.18M378.91M364.94M318.64M288.64M234.86M168.88M-5.06M66.39M5.98M98.5M30.4M5.9M
Discontinued Operations000000000000000000000000000000
Minority Interest41.13M41.23M42.2M43.17M42.51M42.51M42.51M42.51M43.16M000000000000000000000
EPS (Diluted)5.095.054.254.494.445.323.713.472.472.962.712.852.622.532.311.861.691.581.741.651.481.351.080.77-0.020.290.030.490.190.05
EPS Growth %5.93%18.82%-5.35%1.13%-16.54%43.4%6.92%40.49%-16.55%9.23%-4.91%8.78%3.56%9.52%24.19%10.06%6.96%-9.2%5.45%11.49%9.63%25%40.26%3447.83%-107.93%866.67%-93.88%157.89%280%-
EPS (Basic)-5.084.274.524.475.363.733.492.492.992.742.892.652.562.331.871.701.611.831.761.571.441.130.78-0.020.300.030.500.190.05
Diluted Shares Outstanding107.47M111.75M113.96M118.49M121.89M127.97M133.25M137.16M143.7M147.43M151.18M156.81M161.34M163.12M169.44M186.56M204.08M207.61M219.61M223.26M218.53M217.16M220.28M219.88M220.36M226.83M216.94M200.26M159.44M196.8M
Basic Shares Outstanding107.09M111.15M113.3M117.66M121.05M127.18M132.61M136.47M142.42M146.02M149.17M154.42M159.01M161.33M168.28M185.21M202.58M202.87M206.59M207.85M203.19M201.02M208.73M215.85M220.36M222M212M197.44M158.53M196.8M
Dividend Payout Ratio-39.74%42.98%36.89%33.86%25.78%32.95%30.79%37.89%27.82%26.7%22.59%21.54%20.37%--------------1590.37%305.08%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Carrier Capex Concentration Risk

Revenue Growth Faces Cyclical Headwinds

As reported in recent financial filings, Amdocs experienced a notable period of contraction with year-over-year revenue growth dipping to -9.43% in 2025Q2, highlighting the sensitivity of its project-based delivery model to the shifting capital expenditure cycles of its primary North American telecommunications carrier clients.

The recent revenue volatility suggests that the company's reliance on large-scale digital transformation projects leaves it vulnerable to the discretionary spending patterns of a concentrated client base. While the return to positive growth in 2026Q2 is encouraging, investors should monitor whether this reflects a sustainable recovery or merely the timing of milestone-based revenue recognition.

Structural Constraints on Gross Margins

Based on the company's reported figures, gross margins have remained tightly clustered around the 37% level, reflecting the high-touch, labor-intensive nature of its hybrid software and managed services delivery model which limits the scalability typically seen in pure-play enterprise software firms.

The inability to significantly expand gross margins beyond this range suggests that the company remains tethered to high personnel costs required for custom systems integration. This profile warrants further investigation into whether management can successfully transition toward more standardized, cloud-native modules to decouple revenue growth from headcount expansion.

Operating Leverage Remains Under Pressure

According to the income statement data, operating margins have fluctuated between 8.9% and 17.9% over the last ten quarters, indicating that the company struggles to achieve consistent operating leverage as SG&A expenses often offset gains in gross profit during periods of revenue volatility.

The lack of a clear upward trend in operating margins implies that the firm's cost structure is relatively rigid, likely due to the specialized nature of its global engineering workforce. Investors should interpret these fluctuations as a sign that the company's profitability is highly sensitive to the efficiency of its project delivery cycles.

Earnings Quality Impacted by SBC

As evidenced by the historical income statement, the company utilized stock-based compensation of approximately $26 million per quarter through 2025Q3, which, while now absent in recent filings, previously served as a meaningful non-cash expense that impacted the quality of reported net income and diluted EPS.

The cessation of stock-based compensation in recent quarters appears to have provided a mechanical boost to net income, though this should be viewed as a change in accounting presentation rather than an operational improvement. Analysts should remain cautious of how such non-operating items influence the perceived earnings trajectory of the business.

Concentration Risks Challenge Growth Narrative

Based on the provided data, the company's heavy reliance on a small cohort of North American carriers creates a structural vulnerability, as evidenced by the -9.43% revenue decline in 2025Q2 which suggests that the firm lacks the diversification to offset localized downturns in carrier spending.

Short-term observers may argue that the company's 'sticky' managed services are insufficient to protect the top line when major clients undergo significant consolidation or budget tightening. This concentration risk suggests that the company's long-term growth durability may be more fragile than the 'annuity-like' narrative implies.

DOX — Frequently Asked Questions

Quick answers to the most common questions about buying DOX stock.

What was Amdocs Limited's (DOX) revenue in 2025?

For fiscal year 2025, Amdocs Limited (DOX) reported total revenue of $4.53B. This represents a 1462.5% increase compared to $290.1M in 1997.

Is Amdocs Limited (DOX) profitable?

Amdocs Limited (DOX) is profitable, generating $564.7M in net income for the fiscal year ending 2025 with a net profit margin of 12.5%.

What is Amdocs Limited's operating profit margin?

Amdocs Limited (DOX) reported an operating income of $823.4M, resulting in an operating profit margin of 18.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Amdocs Limited's gross profit and gross margin?

Amdocs Limited (DOX) generated $1.66B in gross profit for the year, representing a gross profit margin of 36.6%. This demonstrates the company's core pricing power and production efficiency.